Press releaseGlobe Newswire
IR-Med
IRME · OTC
Price unavailable right now.
No price history for this range.
Latest news
- Press releaseNewsfile
IR-MED Ltd. Announces Launch of First-in-Human Clinical Trial of Its DiaSafe(TM) Device for Diabetic Foot Ulcer (DFU) Assessment
- Press releaseNewsfile
IR-MED's Key Clinical and Media Milestones
- Press releaseNewsfile
IR-MED Investor Update Letter - Sept-2025
- Press releaseNewsfile
IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones
- Press releaseNewsfile
IR-MED Awarded $500,000 Grant from the Israel Innovation Authority to Advance AI-Powered DiaSafe(TM) Device for Diabetic Foot Ulcer Assessment
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.